Related Experiment Videos
[Sites of lymphomas]
J Gabarre1, B Bikandou, J L Binet
1Service d'hématologie, hôpital Pitié-Salpêtrière, Paris.
La Revue Du Praticien
|September 1, 1993
Summary
Non-Hodgkin's lymphomas are cancers of lymphatic tissue that can affect any organ. Diagnosis and prognosis depend on tumor histology and size, not clinical presentation, with specific treatments for certain types.
Area of Science:
- Oncology
- Hematology
- Pathology
Context:
- Non-Hodgkin's lymphomas (NHL) are malignant neoplasms originating from lymphoid tissue.
- NHL can involve lymph nodes and extranodal sites, presenting diverse clinical manifestations.
- The Ann Arbor classification categorizes extranodal lymphomas into localized primary and disseminated secondary types.
Purpose:
- To elucidate the distribution patterns and diagnostic challenges of extranodal Non-Hodgkin's lymphomas.
- To emphasize the prognostic factors and specific treatment considerations for various lymphoma presentations.
Summary:
- Non-Hodgkin's lymphomas predominantly affect lymph nodes but can involve any organ, including extranodal sites.
- Primary extranodal lymphomas commonly occur in the digestive tract and E.N.T. region, while secondary lymphomas frequently involve the bone marrow and liver.
- Diagnosis is challenging due to varied clinical presentations, especially in difficult-to-biopsy locations like the brain. Prognosis relies solely on histology and tumor size.
Impact:
- Highlights the importance of histological and size-based assessment for Non-Hodgkin's lymphoma prognosis.
- Underscores the need for tailored treatment strategies, particularly for cerebromeningeal and cutaneous lymphomas.
- Improves understanding of extranodal lymphoma distribution and diagnostic complexities for clinicians and researchers.